Is investment in science the path to future economic prosperity?
This international conference will bring together political leaders, investors, scientists, industrialists, experts, analysts and commentators to examine the relevance and role of science in building prosperity and enhancing the quality of life. Key questions addressed will include:
What role can science and innovation play in encouraging economic growth?
What solutions can science provide in tackling global challenges such as security, health and climate change?
What impact does investment in science have on an economy?
What policy action is required to encourage such investment and where is it best directed?
Alice S Huang
Dr. Alice S. Huang is President of The American Association for the Advancement of Science.
Dr. Menelas N. Pangalos is Executive Vice President of Innovative Medicines at AstraZeneca.
Dr. Menelas Pangalos, Executive Vice President of Innovative Medicines at AstraZeneca, discusses the rising cost of prescription drug research. He explains that an inability to scale-up, combined with increased patient demands, has driven the price of developing a new drug to around $1.6 billion -- more than it costs to launch a space shuttle into orbit.